Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003141677 | SCV003828101 | uncertain significance | not provided | 2022-01-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004725660 | SCV005338978 | likely pathogenic | COL1A2-related disorder | 2024-09-13 | no assertion criteria provided | clinical testing | The COL1A2 c.2187+5G>A variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Variants affecting the canonical splice site (c.2187+1G>C, c.2187+2T>C) have been reported in individuals with osteogenesis imperfecta (Table S7, Stranneheim et al. 2021. PubMed ID: 33726816; Lee et al. 2006. PubMed ID: 16705691). At PreventionGenetics, this variant was found to be de novo in an individual with features consistent with COL1A2-related disease (Internal Data). This variant is interpreted as likely pathogenic. |